Sector portfolio · Private equity · United States
Foresite Capital's Pharma portfolio
Foresite Capital has backed 12 Pharma startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Vaxcyte.
Foresite Capital's whole portfolioForesite Capital's profile
Funding by segment
- Stage not reported$1.2B5
- Series B$686M5
- Series C and later$341M2
Where they are based
- United States9$1.6B
- United Kingdom2$370M
- Ireland1$268M
United States
United Kingdom
IrelandFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M3
- $50M to $250M5
- $250M to $1B4
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- United Kingdom2
- Ireland1
Startups by country, 3 countries in all.
Segment by segment
Stage not reported
5 startups · $1.2B raised
VaxcyteVaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.United States$633M
Cullinan TherapeuticsCullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.United States$280M
GH ResearchGH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.Ireland$268M
ImageneBioImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseasesUnited States$30M
ALX OncologyALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.United States$10M
Series B
5 startups · $686M raised
EvonetixEvonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.United Kingdom$276M
Seaport TherapeuticsSeaport Therapeutics operates as a clinical stage biopharmaceutical company.United States$240M
Pinnacle MedicinesPinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.United States$90M
Aeovian PharmaceuticalsAeovian Pharmaceuticals, Inc.United States$55M
PlenoSAAS for Carbon Project DevelopersUnited States$25M
Series C and later
2 startups · $341M raised
ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
GenomicsGenomics Ltd, founded in 2014 in Oxford, UK, is a global techbio and precision medicine company.United Kingdom$93M
How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Foresite Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Foresite Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.